Citigroup Issues Pessimistic Forecast for agilon health (NYSE:AGL) Stock Price

agilon health (NYSE:AGL) had its price target cut by Citigroup from $2.50 to $1.75 in a report published on Wednesday,Benzinga reports. They currently have a sell rating on the stock.

A number of other equities research analysts have also weighed in on AGL. JMP Securities lowered agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Bank of America lowered agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective on the stock. in a research report on Wednesday, October 2nd. TD Cowen reduced their price objective on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. Barclays reduced their price objective on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research report on Monday, November 11th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $8.00 price objective on shares of agilon health in a research report on Wednesday, August 7th. Three analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $6.38.

agilon health Price Performance

agilon health stock opened at $1.59 on Wednesday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. agilon health has a 52 week low of $1.58 and a 52 week high of $13.76. The stock has a market capitalization of $653.05 million, a P/E ratio of -1.69 and a beta of 0.60. The stock has a fifty day moving average of $3.05 and a 200-day moving average of $4.86.

agilon health (NYSE:AGL) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same period last year, the firm posted ($0.06) EPS. On average, sell-side analysts expect that agilon health will post -0.43 earnings per share for the current fiscal year.

Insider Activity at agilon health

In other news, CEO Steven Sell bought 20,000 shares of agilon health stock in a transaction on Thursday, September 12th. The shares were purchased at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the acquisition, the chief executive officer now owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. The trade was a 42.03 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. 3.20% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. grew its holdings in shares of agilon health by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock worth $176,582,000 after acquiring an additional 371,537 shares during the period. AQR Capital Management LLC grew its stake in shares of agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after buying an additional 1,316,990 shares during the last quarter. Susquehanna Fundamental Investments LLC grew its stake in shares of agilon health by 65.0% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after buying an additional 316,856 shares during the last quarter. Capital International Investors grew its stake in shares of agilon health by 84.7% in the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock worth $123,207,000 after buying an additional 9,263,296 shares during the last quarter. Finally, Simplicity Wealth LLC grew its stake in shares of agilon health by 145.1% in the 2nd quarter. Simplicity Wealth LLC now owns 26,210 shares of the company’s stock worth $171,000 after buying an additional 15,515 shares during the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.